Pfizer COVID-19 vaccine is safe for children aged 5-11, confirms clinical trial results, reports AFP. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press. Earlier this month, FDA chief Dr. Peter …
